Protembis Announces Completion of ? 30 Million Series B Fina

Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a ? 30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE)...

Related Keywords

Boston , Massachusetts , United States , Italy , United Kingdom , British , Azin Parhizgar , Keithd Dawkins , Protembis Gmbh , Boston Scientific , Product Service , British Cardiovascular Intervention Society , Techvision Fund , Ventric Health , Fulbright Scholar At Stanford University , Jenavalve Technology Inc , Announces Completion , Seriesb Financing Round , Device Exemption , Pivotal Trial , Sweden Based Segulah Medical Acceleration , Germany Based Techvision , Conrad Rasmus , Fulbright Scholar , Stanford University , Chief Medical Officer , Protembo System , Cerebral Protection System , Cerebral Protection ,